Twist Bioscience Corp financial data

Symbol
TWST on Nasdaq
Location
681 Gateway Blvd., South San Francisco, CA
Fiscal year end
September 30
Latest financial report
10-Q - Q1 2025 - May 5, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 481 % -17.8%
Quick Ratio 33.5 % -28%
Debt-to-equity 32.1 % +32%
Return On Equity -41.1 % -30.1%
Return On Assets -31.1 % -22.4%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 59.9M shares +2.9%
Common Stock, Shares, Outstanding 59.9M shares +2.91%
Entity Public Float 1.92B USD +130%
Common Stock, Value, Issued 0 USD
Weighted Average Number of Shares Outstanding, Basic 59.6M shares +3.24%
Weighted Average Number of Shares Outstanding, Diluted 59.6M shares +3.24%

Income Statement

Label TTM Value / Value Unit Change %
Cost of Revenue 185M USD +8.22%
Research and Development Expense 88.8M USD -7.01%
Costs and Expenses 549M USD +13.3%
Operating Income (Loss) -201M USD +2.7%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -191M USD +0.26%
Income Tax Expense (Benefit) 367K USD -57.6%
Net Income (Loss) Attributable to Parent -191M USD +0.52%
Earnings Per Share, Basic -3 USD/shares +3.27%
Earnings Per Share, Diluted -3 USD/shares +3.27%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 210M USD -13.5%
Cash, Cash Equivalents, and Short-term Investments 289M USD -19.8%
Accounts Receivable, after Allowance for Credit Loss, Current 49.9M USD +38.8%
Inventory, Net 20.9M USD -31.3%
Assets, Current 338M USD -8.99%
Property, Plant and Equipment, Net 97.1M USD -19.9%
Operating Lease, Right-of-Use Asset 54.1M USD -15.1%
Goodwill 85.8M USD 0%
Other Assets, Noncurrent 3.69M USD -31.5%
Assets 596M USD -15.3%
Accounts Payable, Current 8.06M USD +4.67%
Employee-related Liabilities, Current 24.9M USD -1.17%
Accrued Liabilities, Current 19.6M USD +34.8%
Liabilities, Current 75M USD +11.1%
Operating Lease, Liability, Noncurrent 65.1M USD -13%
Other Liabilities, Noncurrent 451K USD +7.13%
Liabilities 156M USD +8.96%
Accumulated Other Comprehensive Income (Loss), Net of Tax -662K USD -0.3%
Retained Earnings (Accumulated Deficit) -1.31B USD -17%
Stockholders' Equity Attributable to Parent 440M USD -21.4%
Liabilities and Equity 596M USD -15.3%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -21.4M USD +6.73%
Net Cash Provided by (Used in) Financing Activities 17.9M USD
Net Cash Provided by (Used in) Investing Activities -1.54M USD -137%
Common Stock, Shares Authorized 200M shares +100%
Common Stock, Shares, Issued 59.9M shares +2.91%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -5.07M USD +74.8%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 213M USD -13.5%
Deferred Tax Assets, Valuation Allowance 361M USD +19.3%
Deferred Tax Assets, Gross 379M USD +13.3%
Operating Lease, Liability 80.3M USD -10.2%
Depreciation 25.9M USD -8.8%
Payments to Acquire Property, Plant, and Equipment 2.27M USD +50.6%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -191M USD -0.36%
Lessee, Operating Lease, Liability, to be Paid 126M USD -10.4%
Property, Plant and Equipment, Gross 185M USD -0.66%
Operating Lease, Liability, Current 15.2M USD +4.08%
Lessee, Operating Lease, Liability, to be Paid, Year Two 8.37M USD -39.7%
Lessee, Operating Lease, Liability, to be Paid, Year One 13.9M USD -6.27%
Operating Lease, Weighted Average Discount Rate, Percent 0.06 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 45.9M USD -10.7%
Lessee, Operating Lease, Liability, to be Paid, Year Three 8.47M USD +1.2%
Deferred Tax Assets, Operating Loss Carryforwards 227M USD +8.42%
Unrecognized Tax Benefits 22.4M USD +16.8%
Lessee, Operating Lease, Liability, to be Paid, Year Four 6.61M USD -22%
Operating Lease, Payments 14.7M USD +0.02%
Additional Paid in Capital 1.75B USD +4.23%
Amortization of Intangible Assets 2.1M USD -59.6%
Depreciation, Depletion and Amortization 6.38M USD -21.9%
Deferred Tax Assets, Net of Valuation Allowance 18.2M USD -42.8%
Share-based Payment Arrangement, Expense 58.4M USD +23.8%
Interest Expense 2K USD -92.9%